Patents by Inventor Joo-eun Bae

Joo-eun Bae has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic peptides
    Patent number: 9289479
    Abstract: The invention provides relatively short immunogenic peptides derived from CD19 and CD20 antigens, and biologically active variants thereof, which elicit an immune response. Nucleic acids encoding the immunogenic peptides and antibodies specific for the peptides are also provided. The immunogenic peptides can be included in pharmaceutical compositions, such as cancer vaccines, and used for the treatment of cancer.
    Type: Grant
    Filed: March 2, 2011
    Date of Patent: March 22, 2016
    Assignee: Rush University Medical Center
    Inventor: Joo-eun Bae
  • Immunogenic peptides
    Patent number: 8124069
    Abstract: The invention provides relatively short immunogenic peptides, and biologically active variants thereof, associated with leukemia which elicit an immune response. Nucleic acids encoding the immunogenic peptides and antibodies specific for the peptides are also provided. The immunogenic peptides can be included in pharmaceutical compositions, such as cancer vaccines, and used for the treatment of cancer.
    Type: Grant
    Filed: March 20, 2009
    Date of Patent: February 28, 2012
    Assignee: Rush University Medical Center
    Inventors: Joo-Eun Bae, Hans-G. Klingemann
  • IMMUNOGENIC PEPTIDES
    Publication number: 20110165185
    Abstract: The invention provides relatively short immunogenic peptides derived from CD19 and CD20 antigens, and biologically active variants thereof, which elicit an immune response. Nucleic acids encoding the immunogenic peptides and antibodies specific for the peptides are also provided. The immunogenic peptides can be included in pharmaceutical compositions, such as cancer vaccines, and used for the treatment of cancer.
    Type: Application
    Filed: March 2, 2011
    Publication date: July 7, 2011
    Inventor: Joo-eun Bae
  • Immunogenic CD19 peptides
    Patent number: 7919576
    Abstract: The invention provides relatively short immunogenic peptides derived from CD19 antigens, and biologically active variants thereof, which elicit an immune response. Nucleic acids encoding the immunogenic peptides and antibodies specific for the peptides are also provided. The immunogenic peptides can be included in pharmaceutical compositions, such as cancer vaccines, and used for the treatment of cancer.
    Type: Grant
    Filed: September 8, 2008
    Date of Patent: April 5, 2011
    Assignee: Rush University Medical Center
    Inventor: Joo-eun Bae
  • Immunogenic peptides
    Patent number: 7812116
    Abstract: The invention provides relatively short immunogenic peptides derived from CD19 and CD20 antigens, and biologically active variants thereof, which elicit an immune response. Nucleic acids encoding the immunogenic peptides and antibodies specific for the peptides are also provided. The immunogenic peptides can be included in pharmaceutical compositions, such as cancer vaccines, and used for the treatment of cancer.
    Type: Grant
    Filed: July 2, 2004
    Date of Patent: October 12, 2010
    Assignee: Rush University Medical Center
    Inventor: Joo-eun Bae
  • IMMUNOGENIC PEPTIDES
    Publication number: 20090227020
    Abstract: The invention provides relatively short immunogenic peptides, and biologically active variants thereof, associated with leukemia which elicit an immune response. Nucleic acids encoding the immunogenic peptides and antibodies specific for the peptides are also provided. The immunogenic peptides can be included in pharmaceutical compositions, such as cancer vaccines, and used for the treatment of cancer.
    Type: Application
    Filed: March 20, 2009
    Publication date: September 10, 2009
    Inventors: Joo-eun BAE, Hans-G. KLINGEMANN
  • Immunogenic peptides
    Patent number: 7527793
    Abstract: The invention provides relatively short immunogenic peptides, and biologically active variants thereof, associated with leukemia which elicit an immune response. Nucleic acids encoding the immunogenic peptides and antibodies specific for the peptides are also provided. The immunogenic peptides can be included in pharmaceutical compositions, such as cancer vaccines, and used for the treatment of cancer.
    Type: Grant
    Filed: May 2, 2003
    Date of Patent: May 5, 2009
    Assignee: Rush University Medical Center
    Inventors: Joo-eun Bae, Hans-G. Klingemann
  • IMMUNOGENIC CD19 PEPTIDES
    Publication number: 20090068235
    Abstract: The invention provides relatively short immunogenic peptides derived from CD19 antigens, and biologically active variants thereof, which elicit an immune response. Nucleic acids encoding the immunogenic peptides and antibodies specific for the peptides are also provided. The immunogenic peptides can be included in pharmaceutical compositions, such as cancer vaccines, and used for the treatment of cancer.
    Type: Application
    Filed: September 8, 2008
    Publication date: March 12, 2009
    Inventor: Joo-eun Bae
  • Immunogenic peptides
    Publication number: 20050048071
    Abstract: The invention provides relatively short immunogenic peptides derived from CD19 and CD20 antigens, and biologically active variants thereof, which elicit an immune response. Nucleic acids encoding the immunogenic peptides and antibodies specific for the peptides are also provided. The immunogenic peptides can be included in pharmaceutical compositions, such as cancer vaccines, and used for the treatment of cancer.
    Type: Application
    Filed: July 2, 2004
    Publication date: March 3, 2005
    Inventor: Joo-eun Bae
  • Immunogenic peptides
    Publication number: 20040009186
    Abstract: The invention provides relatively short immunogenic peptides, and biologically active variants thereof, associated with leukemia which elicit an immune response. Nucleic acids encoding the immunogenic peptides and antibodies specific for the peptides are also provided. The immunogenic peptides can be included in pharmaceutical compositions, such as cancer vaccines, and used for the treatment of cancer.
    Type: Application
    Filed: May 2, 2003
    Publication date: January 15, 2004
    Applicant: Rush-Presbyterian-St. Luke's Medical Center
    Inventors: Joo-Eun Bae, Hans-G. Klingemann
  • Immunogenic peptides
    Publication number: 20030206916
    Abstract: The invention provides relatively short immunogenic peptides, and biologically active variants thereof, associated with leukemia which elicit an immune response. Nucleic acids encoding the immunogenic peptides and antibodies specific for the peptides are also provided. The immunogenic peptides can be included in pharmaceutical compositions, such as cancer vaccines, and used for the treatment of cancer.
    Type: Application
    Filed: May 3, 2002
    Publication date: November 6, 2003
    Applicant: Rush-Presbyterian-St. Luke's Medical Center
    Inventors: Joo-Eun Bae, Hans-G. Klingemann